showed a trendp = 0.066
In this study, HER2-positivity showed a trend (p = 0.066) toward improved survival in patients with gastric, esophageal and gastroesophageal cancers.
In this study, HER2-positivity showed a trend (p = 0.066) toward improved survival in patients with gastric, esophageal and gastroesophageal cancers.